Global Tumor-on-a-chip Market 2023 by Company, Regions, Type and Application, Forecast to 2029

May 2023 | 89 pages | ID: G51C47173DD1EN
GlobalInfoResearch

Abstracts

According to our latest research, the global Tumor-on-a-chip market size will reach USD 54 million in 2029, growing at a CAGR of 30.8% over the analysis period.

The Tumor-on-a-chip market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Tumor-on-a-chip market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• PDX Model
• CDX Model

Market segment by Application, can be divided into

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

Market segment by players, this report covers

• Cellesce
• Daxiang Biotech
• Mimetas
• InSphero
• Hepregen
• Charles River

Market segment by regions, regional analysis covers

• North America
• Europe
• Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
• South America
• Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Tumor-on-a-chip product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Tumor-on-a-chip, with recent developments and future plans

Chapter 3, the Tumor-on-a-chip competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Tumor-on-a-chip market forecast, by regions, with revenue, from 2023 to 2029.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.

Chapter 7 and 8, to describe Tumor-on-a-chip research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Tumor-on-a-chip
1.2 Classification of Tumor-on-a-chip by Type
  1.2.1 Overview: Global Tumor-on-a-chip Market Size by Type: 2022 Versus 2028
  1.2.2 Global Tumor-on-a-chip Revenue Market Share by Type in 2029
  1.2.3 PDX Model
  1.2.4 CDX Model
1.3 Global Tumor-on-a-chip Market by Application
  1.3.1 Overview: Global Tumor-on-a-chip Market Size by Application: 2023 Versus 2029
  1.3.2 Pharmaceutical & Biotechnology Companies
  1.3.3 Academic & Research Institutes
  1.3.4 Others
1.4 Global Tumor-on-a-chip Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Tumor-on-a-chip Market Drivers
  1.5.2 Tumor-on-a-chip Market Restraints
  1.5.3 Tumor-on-a-chip Trends Analysis

2 COMPANY PROFILES

2.1 Cellesce
  2.1.1 Cellesce Details
  2.1.2 Cellesce Major Business
  2.1.3 Cellesce Tumor-on-a-chip Product and Solutions
  2.1.4 Cellesce Recent Developments and Future Plans
2.2 Daxiang Biotech
  2.2.1 Daxiang Biotech Details
  2.2.2 Daxiang Biotech Major Business
  2.2.3 Daxiang Biotech Tumor-on-a-chip Product and Solutions
  2.2.4 Daxiang Biotech Recent Developments and Future Plans
2.3 Mimetas
  2.3.1 Mimetas Details
  2.3.2 Mimetas Major Business
  2.3.3 Mimetas Tumor-on-a-chip Product and Solutions
  2.3.4 Mimetas Recent Developments and Future Plans
2.4 InSphero
  2.4.1 InSphero Details
  2.4.2 InSphero Major Business
  2.4.3 InSphero Tumor-on-a-chip Product and Solutions
  2.4.4 InSphero Recent Developments and Future Plans
2.5 Hepregen
  2.5.1 Hepregen Details
  2.5.2 Hepregen Major Business
  2.5.3 Hepregen Tumor-on-a-chip Product and Solutions
  2.5.4 Hepregen Recent Developments and Future Plans
2.6 Charles River
  2.6.1 Charles River Details
  2.6.2 Charles River Major Business
  2.6.3 Charles River Tumor-on-a-chip Product and Solutions
  2.6.4 Charles River Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Tumor-on-a-chip Revenue and Share by Players (2023 & 2029)
3.2 Tumor-on-a-chip Players Head Office, Products and Services Provided
3.3 Tumor-on-a-chip Mergers & Acquisitions
3.4 Tumor-on-a-chip New Entrants and Expansion Plans

4 GLOBAL TUMOR-ON-A-CHIP FORECAST BY REGION

4.1 Global Tumor-on-a-chip Market Size by Region: 2023 VS 2029
4.2 Global Tumor-on-a-chip Market Size by Region, (2023-2029)
4.3 North America
  4.3.1 Key Companies of Tumor-on-a-chip in North America
  4.3.2 Current Situation and Forecast of Tumor-on-a-chip in North America
  4.3.3 North America Tumor-on-a-chip Market Size and Prospect (2023-2029)
4.4 Europe
  4.4.1 Key Companies of Tumor-on-a-chip in Europe
  4.4.2 Current Situation and Forecast of Tumor-on-a-chip in Europe
  4.4.3 Europe Tumor-on-a-chip Market Size and Prospect (2023-2029)
4.5 Asia-Pacific
  4.5.1 Key Companies of Tumor-on-a-chip in Asia-Pacific
  4.5.2 Current Situation and Forecast of Tumor-on-a-chip in Asia-Pacific
  4.5.3 Asia-Pacific Tumor-on-a-chip Market Size and Prospect (2023-2029)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Tumor-on-a-chip in South America
  4.6.2 Current Situation and Forecast of Tumor-on-a-chip in South America
  4.6.3 South America Tumor-on-a-chip Market Size and Prospect (2023-2029)
4.7 Middle East & Africa
  4.7.1 Key Companies of Tumor-on-a-chip in Middle East & Africa
  4.7.2 Current Situation and Forecast of Tumor-on-a-chip in Middle East & Africa
  4.7.3 Middle East & Africa Tumor-on-a-chip Market Size and Prospect (2023-2029)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Tumor-on-a-chip Market Forecast by Type (2023-2029)
5.2 Global Tumor-on-a-chip Market Share Forecast by Type (2023-2029)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Tumor-on-a-chip Market Forecast by Application (2023-2029)
6.2 Global Tumor-on-a-chip Market Share Forecast by Application (2023-2029)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Tumor-on-a-chip Revenue by Type, (USD Million), 2023 VS 2029
Table 2. Global Tumor-on-a-chip Revenue by Application, (USD Million), 2023 VS 2029
Table 3. Cellesce Corporate Information, Head Office, and Major Competitors
Table 4. Cellesce Major Business
Table 5. Cellesce Tumor-on-a-chip Product and Solutions
Table 6. Daxiang Biotech Corporate Information, Head Office, and Major Competitors
Table 7. Daxiang Biotech Major Business
Table 8. Daxiang Biotech Tumor-on-a-chip Product and Solutions
Table 9. Mimetas Corporate Information, Head Office, and Major Competitors
Table 10. Mimetas Major Business
Table 11. Mimetas Tumor-on-a-chip Product and Solutions
Table 12. InSphero Corporate Information, Head Office, and Major Competitors
Table 13. InSphero Major Business
Table 14. InSphero Tumor-on-a-chip Product and Solutions
Table 15. Hepregen Corporate Information, Head Office, and Major Competitors
Table 16. Hepregen Major Business
Table 17. Hepregen Tumor-on-a-chip Product and Solutions
Table 18. Charles River Corporate Information, Head Office, and Major Competitors
Table 19. Charles River Major Business
Table 20. Charles River Tumor-on-a-chip Product and Solutions
Table 21. Global Tumor-on-a-chip Revenue (USD Million) by Players (2023 & 2029)
Table 22. Global Tumor-on-a-chip Revenue Share by Players (2023 & 2029)
Table 23. Tumor-on-a-chip Players Head Office, Products and Services Provided
Table 24. Tumor-on-a-chip Mergers & Acquisitions in the Past Five Years
Table 25. Tumor-on-a-chip New Entrants and Expansion Plans
Table 26. Global Market Tumor-on-a-chip Revenue (USD Million) Comparison by Region (2023 VS 2029)
Table 27. Global Tumor-on-a-chip Revenue Market Share by Region (2023-2029)
Table 28. Key Companies of Tumor-on-a-chip in North America
Table 29. Current Situation and Forecast of Tumor-on-a-chip in North America
Table 30. Key Companies of Tumor-on-a-chip in Europe
Table 31. Current Situation and Forecast of Tumor-on-a-chip in Europe
Table 32. Key Companies of Tumor-on-a-chip in Asia-Pacific
Table 33. Current Situation and Forecast of Tumor-on-a-chip in Asia-Pacific
Table 34. Key Companies of Tumor-on-a-chip in China
Table 35. Key Companies of Tumor-on-a-chip in Japan
Table 36. Key Companies of Tumor-on-a-chip in South Korea
Table 37. Key Companies of Tumor-on-a-chip in South America
Table 38. Current Situation and Forecast of Tumor-on-a-chip in South America
Table 39. Key Companies of Tumor-on-a-chip in Middle East & Africa
Table 40. Current Situation and Forecast of Tumor-on-a-chip in Middle East & Africa
Table 41. Global Tumor-on-a-chip Revenue Forecast by Type (2023-2029)
Table 42. Global Tumor-on-a-chip Revenue Forecast by Application (2023-2029)

List Of Figures

LIST OF FIGURES

Figure 1. Tumor-on-a-chip Picture
Figure 2. Global Tumor-on-a-chip Revenue Market Share by Type in 2029
Figure 3. PDX Model
Figure 4. CDX Model
Figure 5. Tumor-on-a-chip Revenue Market Share by Application in 2029
Figure 6. Pharmaceutical & Biotechnology Companies Picture
Figure 7. Academic & Research Institutes Picture
Figure 8. Others Picture
Figure 9. Global Tumor-on-a-chip Market Size, (USD Million): 2023 VS 2029
Figure 10. Global Tumor-on-a-chip Revenue and Forecast (2023-2029) & (USD Million)
Figure 11. Tumor-on-a-chip Market Drivers
Figure 12. Tumor-on-a-chip Market Restraints
Figure 13. Tumor-on-a-chip Market Trends
Figure 14. Cellesce Recent Developments and Future Plans
Figure 15. Daxiang Biotech Recent Developments and Future Plans
Figure 16. Mimetas Recent Developments and Future Plans
Figure 17. InSphero Recent Developments and Future Plans
Figure 18. Hepregen Recent Developments and Future Plans
Figure 19. Charles River Recent Developments and Future Plans
Figure 20. Global Tumor-on-a-chip Revenue Market Share by Region (2023-2029)
Figure 21. Global Tumor-on-a-chip Revenue Market Share by Region in 2029
Figure 22. North America Tumor-on-a-chip Revenue (USD Million) and Growth Rate (2023-2029)
Figure 23. Europe Tumor-on-a-chip Revenue (USD Million) and Growth Rate (2023-2029)
Figure 24. Asia-Pacific Tumor-on-a-chip Revenue (USD Million) and Growth Rate (2023-2029)
Figure 25. South America Tumor-on-a-chip Revenue (USD Million) and Growth Rate (2023-2029)
Figure 26. Middle East & Africa Tumor-on-a-chip Revenue (USD Million) and Growth Rate (2023-2029)
Figure 27. Global Tumor-on-a-chip Market Share Forecast by Type (2023-2029)
Figure 28. Global Tumor-on-a-chip Market Share Forecast by Application (2023-2029)
Figure 29. Methodology
Figure 30. Research Process and Data Source